A systematic review [81] assessed the available data on the potential effect of GLP-1RAs on the reward system
Effect of oral semaglutide on glycemic control
CLINICAL PRACTICE CONSIDERATIONS Cardiovascular-kidney-metabolic traits The choice between SGLT2 inhibitors and GLP-1 receptor agonists for managing DKD should be guided by a comprehensive assessment of an individuals cardiovascular-kidney-metabolic (CKM) health [83]
Instead, they measure the alcohol concentration in the deep lung air
In that framework, the pineal gland occupies a central place because of its relationship to melatonin secretion, circadian signaling, and neuroendocrine aging
Future improvements in RL frameworks should include integrating experimental data for better prediction accuracy, leveraging advanced machine learningespecially deep learningfor clinical property prediction, and incorporating clinically relevant features into the reward function to refine optimization strategies